AcelRx (ACRX) stock made a new 52-week high of $2.12 on Jan. 12. However, the stock fell almost 9 percent on the next trading day. It's among the biggest gainers in 2021 with a YTD rise of over 60 ...

In this article we are going to use hedge fund sentiment as a tool and determine whether AcelRx Pharmaceuticals Inc (NASDAQ:ACRX) is a good investment right now. We like to analyze hedge fund ...

AcelRx Pharmaceuticals sold its opioid business in March 2023 at terms that were substantially below my previous expectations. The company raised capital in December 2022, causing a roughly 50% ...

AcelRx Pharmaceuticals, Inc. ACRX was a big mover last session, as the company saw its shares rise more than 5% on the day. The move came on solid volume too with far more shares changing hands than ...

Investors in AcelRx Pharmaceuticals, Inc. ACRX need to pay close attention to the stock based on moves in the options market lately. That is because the Mar 19, 2021 $5.00 Call had some of the highest ...

After weighing all of those recent new insights into the company’s future path, I spent quite some time on considering my updated rating on ACRX. Eventually, I decided to stick to my Neutral rating ...

Investors in AcelRx Pharmaceuticals, Inc. ACRX need to pay close attention to the stock based on moves in the options market lately. That is because the Nov 20, 2020 $2.50 Call had some of the highest ...

Before we spend countless hours researching a company, we like to analyze what insiders, hedge funds and billionaire investors think of the stock first. This is a necessary first step in our ...

AcelRx Pharmaceuticals, Inc. (Nasdaq: ACRX), (AcelRx), a specialty pharmaceutical company focused on the development and commercialization of innovative therapies for use in medically supervised ...

• Soligenix, Inc. SNGX shares increased by 27.03% to $1.88 during Thursday's pre-market session. • Helius Medical, Inc. HSDT shares moved upwards by 18.81% to $0.48. • AcelRx Pharmaceuticals, Inc.